US2009054355A1PendingUtilityA1

Proliferation Inhibitor Of Helicobacter Pylori Including Alpha-N-Acetyl-Glucosaminyl Bond-Containing Monosaccharide Derivatives

Assignee: UNIV SHINSHUPriority: Jan 12, 2007Filed: Jan 12, 2007Published: Feb 26, 2009
Est. expiryJan 12, 2027(~0.5 yrs left)· nominal 20-yr term from priority
A61P 31/00A61P 31/04A61P 35/00A23L 33/10A61K 31/7028A61P 1/04C07H 5/04
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention herein provides a proliferation inhibitor of Helicobacter pylori comprising a compound that can simply be mass-produced, can specifically inhibit the proliferation of H. pylori, which has high safety and never generates any resistant bacteria, as well as a diet of a food or beverage, and a pharmaceutical preparation containing the proliferation inhibitor of Helicobacter pylori. The proliferation inhibitor of Helicobacter pylori comprises an alpha-N-acetyl-glucosaminyl bond-containing monosaccharide derivative represented by the following chemical formula (1) GlcNAc 1 -alpha-O-Y   (1) (in the formula (1), Y is a straight-, branched- or cyclic-aliphatic hydrocarbon group having 1 to 27 carbon atoms or a straight-, branched- or cyclic-acyl group having 1 to 27 carbon atoms). The diet of the food, the beverage or the pharmaceutical preparation comprises the proliferation inhibitor of Helicobacter pylori.

Claims

exact text as granted — not AI-modified
1 . A proliferation inhibitor of Helicobacter pylori comprising an alpha-N-acetyl-glucosaminyl bond-containing monosaccharide derivative represented by the following chemical formula (1)
   GlcNAc1-alpha-O-Y   (1)   
     (in the formula (1), Y is a straight-, branched- or cyclic-aliphatic hydrocarbon group having 1 to 27 carbon atoms; or a straight-, branched- or cyclic-acyl group having 1 to 27 carbon atoms). 
   
   
       2 . A diet of a food or a beverage comprising a proliferation inhibitor of Helicobacter pylori comprising an alpha-N-acetyl-glucosaminyl bond-containing monosaccharide derivative represented by the following chemical formula (1)
   GlcNAc1-alpha-O-Y   (1)   
     (in the formula (1), Y is a straight-, branched- or cyclic-aliphatic hydrocarbon group having 1 to 27 carbon atoms or a straight-, branched- or cyclic-acyl group having 1 to 27 carbon atoms). 
   
   
       3 . A pharmaceutical preparation comprising a proliferation inhibitor of Helicobacter pylori comprising an alpha-N-acetyl-glucosaminyl bond-containing monosaccharide derivative represented by the following chemical formula (1)
   GlcNAc1-alpha-O-Y   (1)   
     (in the formula (1), Y is a straight-, branched- or cyclic-aliphatic hydrocarbon group having 1 to 27 carbon atoms or a straight-, branched- or or cyclic-acyl group having 1 to 27 carbon atoms).

Join the waitlist — get patent alerts

Track US2009054355A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.